These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2146425)

  • 21. Circadian blood pressure changes and cardiac geometry in essential arterial hypertension.
    Czarnecka D; Kawecka-Jaszcz K; Lubaszewski W; Rajzer M; Curyło A
    J Hum Hypertens; 1996 Sep; 10 Suppl 3():S95-8. PubMed ID: 8872837
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ambulatory blood pressure monitoring and echocardiographic left ventricular wall thickness and mass.
    Prisant LM; Carr AA
    Am J Hypertens; 1990 Feb; 3(2):81-9. PubMed ID: 2137704
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Left heart hypertrophy in arterial hypertension in relation to hemodynamic and humoral factors].
    Punzengruber C; Stanek B; Silberbauer K
    Acta Med Austriaca; 1989; 16(1):23-6. PubMed ID: 2652976
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Normalization of left ventricular mass and associated changes in neurohormones and atrial natriuretic peptide after 1 year of sustained nifedipine therapy for severe hypertension.
    Phillips RA; Ardeljan M; Shimabukuro S; Goldman ME; Garbowit DL; Eison HB; Krakoff LR
    J Am Coll Cardiol; 1991 Jun; 17(7):1595-602. PubMed ID: 1827811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Differences in hemodynamic responses to dynamic exercise between borderline and sustained hypertension].
    Shimizu M; Tsuyusaki T; Noro C; Kawaguchi T; Mochizuki T; Kawano M; Kuramochi K; Kikawada R; Nakazawa K; Ishii K
    J Cardiol; 1987 Jun; 17(2):285-99. PubMed ID: 2966243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hemodynamic, humoral and volume findings in systemic hypertension with isolated ventricular septal hypertrophy.
    Schmieder RE; Messerli FH; Nunez BD; Garavaglia GE; Frohlich ED
    Am J Cardiol; 1988 Nov; 62(16):1053-7. PubMed ID: 2973218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Echocardiographic features of left ventricular hypertrophy and contractility in malignant hypertension].
    Nakamura Y; Arita M; Fujiwara S; Tomobuchi Y; Nakamura H; Shiotani M; Yamamoto K; Ueno Y; Nishio I; Masuyama Y
    J Cardiol; 1989 Mar; 19(1):125-34. PubMed ID: 2530333
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endogenous ouabain and hemodynamic and left ventricular geometric patterns in essential hypertension.
    Pierdomenico SD; Bucci A; Manunta P; Rivera R; Ferrandi M; Hamlyn JM; Lapenna D; Cuccurullo F; Mezzetti A
    Am J Hypertens; 2001 Jan; 14(1):44-50. PubMed ID: 11206678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diminished nocturnal decline in blood pressure in elderly hypertensive patients with left ventricular hypertrophy.
    Kuwajima I; Suzuki Y; Shimosawa T; Kanemaru A; Hoshino S; Kuramoto K
    Am Heart J; 1992 May; 123(5):1307-11. PubMed ID: 1533487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiac diastolic abnormalities and atrial natriuretic factor in essential hypertension.
    Pontremoli R; Bezante GP; Robaudo C; Massarino F; Sofia A; Bertero G; Gnecco G; Pastorini C
    Eur Heart J; 1993 Jul; 14(7):910-4. PubMed ID: 8375414
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Left ventricular structural and functional characteristics in patients with renovascular hypertension, primary aldosteronism and essential hypertension.
    Yoshihara F; Nishikimi T; Yoshitomi Y; Nakasone I; Abe H; Matsuoka H; Omae T
    Am J Hypertens; 1996 Jun; 9(6):523-8. PubMed ID: 8783775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma levels of atrial natriuretic factor in mild to moderate hypertensives without signs of left ventricular hypertrophy: correlation with the known duration of hypertension.
    Dessì-Fulgheri P; Palermo R; Di Noto G; Conti V; Rinaldi L; Tesei G; Russo P; Rappelli A
    J Hum Hypertens; 1988 Oct; 2(3):177-82. PubMed ID: 2976835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in plasma cardiac natriuretic peptides concentrations during 1 year treatment with angiotensin-converting enzyme inhibitor in elderly hypertensive patients with left ventricular hypertrophy.
    Kohno M; Yokokawa K; Yasunari K; Kano H; Minami M; Hanehira T; Yoshikawa J
    Int J Clin Pharmacol Ther; 1997 Jan; 35(1):38-42. PubMed ID: 9021441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blunted sympathetic response to cardiopulmonary receptor unloading in hypertensive patients with left ventricular hypertrophy. A possible compensatory role of atrial natriuretic factor.
    Trimarco B; Lembo G; De Luca N; Volpe M; Ricciardelli B; Condorelli G; Rosiello G; Condorelli M
    Circulation; 1989 Oct; 80(4):883-92. PubMed ID: 2529058
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Left ventricular structure and determinants in normotensive offspring of essential hypertensive parents.
    Allemann Y; Aeschbacher B; Zwyssig P; Ferrari P; Hopf M; Shaw S; Gurtner HP; Weidmann P
    J Hypertens; 1992 Oct; 10(10):1257-64. PubMed ID: 1335009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of humoral and neurohormonal factors on cardiovascular hypertrophy in untreated essential hypertensives.
    Schroeder AP; Sihm I; Mørn B; Thygesen K; Pedersen EB; Lederballe O
    Am J Hypertens; 1996 Mar; 9(3):207-15. PubMed ID: 8695018
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Whole blood viscosity as a determinant of cardiac hypertrophy in systemic hypertension.
    Devereux RB; Drayer JI; Chien S; Pickering TG; Letcher RL; DeYoung JL; Sealey JE; Laragh JH
    Am J Cardiol; 1984 Sep; 54(6):592-5. PubMed ID: 6236687
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relation of plasma brain and atrial natriuretic peptides to left ventricular geometric patterns in essential hypertension.
    Yasumoto K; Takata M; Ueno H; Tomita S; Tomoda F; Inoue H
    Am J Hypertens; 1999 Sep; 12(9 Pt 1):921-4. PubMed ID: 10509551
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiac involvement in adolescent hypertension. Echocardiographic determination of myocardial hypertrophy.
    Zahka KG; Neill CA; Kidd L; Cutilletta MA; Cutilletta AF
    Hypertension; 1981; 3(6):664-8. PubMed ID: 6457795
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Asymmetric ventricular hypertrophy in patients with essential hypertension.
    Nomura G; Kumagai E; Midorikawa K; Kitano T; Tashiro H; Koga Y; Toshima H
    Jpn Heart J; 1982 Mar; 23(2):181-90. PubMed ID: 6210786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.